➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: January 28, 2021

DrugPatentWatch Database Preview

Cefuroxime axetil - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for cefuroxime axetil and what is the scope of freedom to operate?

Cefuroxime axetil is the generic ingredient in two branded drugs marketed by Glaxosmithkline, Sun Pharm Inds Ltd, Alkem Labs Ltd, Ani Pharms Inc, Apotex, Aurobindo Pharma Ltd, Fosun Pharma, Lupin, Orchid Hlthcare, Ranbaxy Labs Ltd, and Wockhardt, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-two drug master file entries for cefuroxime axetil. Seventeen suppliers are listed for this compound.

Drug Prices for cefuroxime axetil

See drug prices for cefuroxime axetil

Drug Sales Revenue Trends for cefuroxime axetil

See drug sales revenues for cefuroxime axetil

Recent Clinical Trials for cefuroxime axetil

Identify potential brand extensions & 505(b)(2) entrants

University of LouisvillePhase 0
Julio RamirezPhase 0
James Graham Brown Cancer CenterPhase 0

See all cefuroxime axetil clinical trials

Pharmacology for cefuroxime axetil

US Patents and Regulatory Information for cefuroxime axetil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065135-001 Jul 25, 2003 AB RX No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline CEFTIN cefuroxime axetil TABLET;ORAL 050605-001 Dec 28, 1987 DISCN Yes No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Ltd CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065118-003 Apr 25, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.